# Laver (Porphyra umbilicalis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/laver
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** Marine-Derived
**Also Known As:** Porphyra umbilicalis, nori, purple laver, red seaweed, sea lettuce, Atlantic laver, edible seaweed, Rhodophyta, marine algae

## Overview

Laver (Porphyra umbilicalis) is a red algae rich in porphyrins, R-phycoerythrin, and sulfated polysaccharides that drive its bioactivity. Its primary mechanisms include [acetylcholine](/ingredients/condition/cognitive)sterase inhibition relevant to cognitive protection and antiproliferative activity against HPV-associated dysplastic tissue.

## Health Benefits

• May help prevent progression of pre-malignant skin lesions - shown to reduce dysplastic lesions in HPV16-transgenic mice by up to 65% (Preliminary evidence)
• Potential anti-Alzheimer's activity - demonstrates 46-89% [acetylcholine](/ingredients/condition/cognitive)sterase inhibitory activity in vitro (Preliminary evidence)
• Antigenotoxic properties - protects against DNA damage as shown in comet/micronucleus assays (Preliminary evidence)
• Rich source of [antioxidant](/ingredients/condition/antioxidant)s including phenolics, flavonoids, and carotenoids (Preliminary evidence)
• Supports gut microbiota modulation through carbohydrates and sulphatases (Preliminary evidence)

## Mechanism of Action

Laver's sulfated polysaccharides and phycobiliproteins, particularly R-phycoerythrin, inhibit [acetylcholine](/ingredients/condition/cognitive)sterase activity in a concentration-dependent manner, reducing hydrolysis of acetylcholine at cholinergic synapses. Its porphyrin pigments and polyphenolic compounds modulate [oxidative stress](/ingredients/condition/antioxidant) pathways, suppressing NF-κB-mediated [inflammatory](/ingredients/condition/inflammation) signaling and inhibiting aberrant keratinocyte proliferation in HPV-driven dysplasia. Additionally, bioactive peptides derived from Porphyra umbilicalis protein hydrolysis may interact with cellular apoptosis pathways, promoting clearance of pre-malignant cells.

## Clinical Summary

Current evidence for Porphyra umbilicalis is predominantly preclinical. In vivo studies using HPV16-transgenic mouse models demonstrated a 65% reduction in dysplastic skin lesions following laver extract administration, though human trials have not yet replicated these findings. [Acetylcholine](/ingredients/condition/cognitive)sterase inhibitory activity of 46–89% has been measured in vitro, placing it within a pharmacologically relevant range, but no human pharmacokinetic or efficacy trials exist for this endpoint. Evidence is classified as preliminary across all claimed benefits, meaning results require validation in randomized controlled human trials before clinical recommendations can be made.

## Nutritional Profile

Laver (Porphyra umbilicalis) is a nutrient-dense red alga with a high protein content of approximately 25-35% dry weight, containing all essential amino acids with notable concentrations of alanine, glycine, and glutamic acid. Carbohydrates comprise roughly 40-60% dry weight, dominated by the sulfated polysaccharide porphyran (a galactan unique to Porphyra spp.) and floridean starch; dietary fiber accounts for approximately 30-50% dry weight. Lipid content is low at 1-5% dry weight, but rich in polyunsaturated fatty acids including eicosapentaenoic acid (EPA, 20:5n-3) at approximately 20-30% of total fatty acids, and arachidonic acid (ARA, 20:4n-6). Vitamins are a key feature: vitamin B12 (cobalamin) is present at 55-77 µg/100g dry weight — one of the highest plant-source concentrations reported, though bioavailability is debated due to potential pseudovitamin B12 analogs; vitamin C (ascorbic acid) at 15-30 mg/100g fresh weight; vitamin A precursors including beta-carotene at approximately 1-3 mg/100g dry weight; and vitamin E (tocopherols) at trace levels. Mineral content is substantial: iodine at 50-200 µg/100g fresh weight (variable by season and location), iron at 15-25 mg/100g dry weight (bioavailability enhanced by co-occurring vitamin C but potentially reduced by phytate interactions), calcium at 150-300 mg/100g dry weight, magnesium at 150-300 mg/100g dry weight, and potassium at 500-1000 mg/100g dry weight. Key bioactive compounds include R-phycoerythrin (phycobiliprotein pigment with [antioxidant](/ingredients/condition/antioxidant) properties, ~0.5-2% dry weight), mycosporine-like amino acids (MAAs, particularly porphyra-334 and shinorine at 1-10 mg/g dry weight, acting as UV-absorbing [photoprotect](/ingredients/condition/skin-health)ive compounds and putative antigenotoxic agents), polyphenolic compounds including bromophenols at low concentrations (~0.1-0.5 mg/g dry weight), and carotenoids including zeaxanthin. Porphyran sulfate fractions have demonstrated the [acetylcholine](/ingredients/condition/cognitive)sterase inhibitory activity noted in existing data. Bioavailability of minerals may be moderated by the alginous cell wall matrix; cooking or processing can improve mineral and protein digestibility by approximately 20-40%.

## Dosage & Preparation

No clinically studied dosages in humans are available. In animal studies, 10% P. umbilicalis powder incorporated into the diet for 22 days was effective and safe with no observed toxicity. No standardized extracts or specific compound concentrations have been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Porphyra umbilicalis is generally regarded as safe when consumed as a dietary food, consistent with its long history in Japanese and Welsh cuisines, but concentrated supplement forms lack formal human safety trials. Its naturally high iodine content poses a risk of [thyroid](/ingredients/condition/hormonal) dysfunction—particularly hypothyroidism or hyperthyroidism—in individuals with pre-existing thyroid conditions or those on thyroid medications such as levothyroxine. Due to anticoagulant properties observed with related algal sulfated polysaccharides, concurrent use with blood thinners including warfarin should be approached cautiously until interaction studies are completed. Safety data during pregnancy and lactation is insufficient to support supplemental use beyond normal dietary amounts.

## Scientific Research

Research on P. umbilicalis is limited to preclinical studies, with no human clinical trials identified. The primary study (PMID: 31671845) used 44 HPV16-transgenic mice fed 10% P. umbilicalis-supplemented diet for 22 days, showing significant reduction in pre-malignant dysplastic skin lesions. Additional in vitro studies demonstrate [acetylcholine](/ingredients/condition/cognitive)sterase inhibitory activity and [antioxidant](/ingredients/condition/antioxidant) properties.

## Historical & Cultural Context

Laver has been widely consumed as a staple food in various cultures, particularly in Asia where it is known as nori in Japan, valued for its nutritional content. While no specific traditional medicine uses in TCM or Ayurveda are documented, modern research positions it as a potential functional food building on its long-standing dietary role.

## Synergistic Combinations

Other sea vegetables, [antioxidant](/ingredients/condition/antioxidant) compounds, omega-3 fatty acids, vitamin D, [probiotic](/ingredients/condition/gut-health)s

## Frequently Asked Questions

### Can laver seaweed help with Alzheimer's disease?

Porphyra umbilicalis extracts have demonstrated 46–89% acetylcholinesterase inhibitory activity in vitro, a mechanism shared by FDA-approved Alzheimer's drugs like donepezil. However, all current data is from cell-based studies, and no human clinical trials have evaluated laver for Alzheimer's prevention or treatment, so it cannot be recommended as a therapeutic agent at this time.

### What is the active compound in laver that fights cancer?

The antiproliferative activity in Porphyra umbilicalis is attributed primarily to sulfated polysaccharides, porphyrins, and R-phycoerythrin, which collectively suppress abnormal cell proliferation. In HPV16-transgenic mouse models, these compounds reduced dysplastic lesion counts by up to 65%, likely through modulation of NF-κB signaling and promotion of apoptosis in pre-malignant keratinocytes.

### How much iodine is in laver seaweed?

Porphyra species, including Porphyra umbilicalis, contain variable iodine levels typically ranging from 16 to over 100 µg per gram dry weight depending on harvesting conditions and season. Regular high-dose supplementation could easily exceed the tolerable upper intake level of 1,100 µg/day for adults, making it especially risky for individuals with Hashimoto's thyroiditis, Graves' disease, or those taking thyroid hormone medications.

### What is laver seaweed used for in traditional diets?

Porphyra umbilicalis has been consumed for centuries, most notably as laverbread in Wales—where it is boiled and formed into cakes—and as a component of coastal Irish cuisine. It provides protein (up to 47% dry weight), vitamins B12 and C, iron, and omega-3 fatty acids, making it a nutritionally dense whole food distinct from concentrated supplement extracts.

### Is Porphyra umbilicalis the same as nori?

Porphyra umbilicalis is closely related to nori (primarily Pyropia yezoensis and Pyropia tenera used in Japanese cuisine) and belongs to the same red algae family Bangiaceae, but it is a distinct species. While they share similar nutritional profiles including high protein, B12, and sulfated polysaccharide content, the specific phytochemical composition and bioactive potency can differ between species and should not be assumed interchangeable for therapeutic purposes.

### Is laver seaweed safe to consume during pregnancy and breastfeeding?

Laver seaweed is generally recognized as safe for consumption during pregnancy and breastfeeding, as it has been used traditionally in Asian diets for centuries. However, due to its high iodine content, pregnant women should monitor total iodine intake to avoid exceeding recommended levels, which could affect thyroid function. Consulting with a healthcare provider about appropriate consumption amounts during these periods is advisable to ensure optimal nutrient balance.

### What is the difference between laver supplements and eating nori sheets, and which form provides better bioavailability?

While laver (Porphyra umbilicalis) and nori are closely related seaweeds, nori is typically processed and dried into sheets, whereas laver supplements may be concentrated or processed differently to isolate specific bioactive compounds. The bioavailability of nutrients like polysaccharides and proteins may vary depending on processing methods, with some evidence suggesting that whole food forms retain more natural synergistic compounds than isolated extracts. Eating whole nori sheets provides additional fiber and maintains the natural nutrient matrix, while standardized supplements offer consistent dosing of specific active constituents.

### Does laver seaweed interact with thyroid medications or iodine supplementation?

Laver seaweed is high in iodine and may interact with thyroid medications or other iodine supplements, potentially affecting hormone levels and medication efficacy in individuals with thyroid conditions. People taking levothyroxine or other thyroid medications should inform their healthcare provider before consuming large amounts of laver, as excessive iodine can disrupt thyroid function. Timing and coordination of laver consumption with thyroid medication dosing may be necessary to avoid absorption interference or iodine accumulation.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*